Dongkuk Pharmaceutical announced the launch of its new dermacosmetic product, the 'Expert Madeca Cream Core Voluming,' on September 4. The company is also running a promotional campaign for the product.
This new cream was co-developed with Taiwanese beauty influencer Marvis, who participated in the product planning phase, including ingredient selection and formulation design, and helped improve the user experience through pre-launch testing.
The 'Expert Madeca Cream Core Voluming' targets five areas: the forehead, under the eyes, core midface, nasolabial folds, and cheeks, addressing issues such as volume loss, sagging skin, and wrinkles. It also aids in firming the double chin and the pores.
The cream contains 5% of the patented volumizing ingredient 'Volufiline™,' developed by French raw material company Sederma. It also incorporates Dongkuk Pharmaceutical's TECA (a standardized extract of Centella Asiatica) combined with 30 types of peptides and ginseng water, branded as 'TECA-PEP™.'
Additionally, the product includes four types of retinoids—retinol, retinal, HPR, and retinyl palmitate—along with NAD+ (Nicotinamide Adenine Dinucleotide). The cream features a highly elastic texture designed to adhere closely to the skin's contours.
A representative from Centellian24 stated, "This product will provide a new option for consumers seeking volume and elasticity care."
As pharmaceutical companies increasingly enter the dermacosmetic market, the sector is experiencing rapid growth. According to market research firm Euromonitor, the average annual growth rate of the domestic skincare market from 2020 to 2025 is projected at 2.1%, while dermacosmetics are expected to grow at a rate of 15.7%, nearly seven times faster.
The size of the dermacosmetic market has more than doubled from 632.1 billion won in 2020 to 1.3079 trillion won last year, increasing its share of the overall skincare market from 9% to 17%.
This new cream was co-developed with Taiwanese beauty influencer Marvis, who participated in the product planning phase, including ingredient selection and formulation design, and helped improve the user experience through pre-launch testing.
The 'Expert Madeca Cream Core Voluming' targets five areas: the forehead, under the eyes, core midface, nasolabial folds, and cheeks, addressing issues such as volume loss, sagging skin, and wrinkles. It also aids in firming the double chin and the pores.
The cream contains 5% of the patented volumizing ingredient 'Volufiline™,' developed by French raw material company Sederma. It also incorporates Dongkuk Pharmaceutical's TECA (a standardized extract of Centella Asiatica) combined with 30 types of peptides and ginseng water, branded as 'TECA-PEP™.'
Additionally, the product includes four types of retinoids—retinol, retinal, HPR, and retinyl palmitate—along with NAD+ (Nicotinamide Adenine Dinucleotide). The cream features a highly elastic texture designed to adhere closely to the skin's contours.
A representative from Centellian24 stated, "This product will provide a new option for consumers seeking volume and elasticity care."
As pharmaceutical companies increasingly enter the dermacosmetic market, the sector is experiencing rapid growth. According to market research firm Euromonitor, the average annual growth rate of the domestic skincare market from 2020 to 2025 is projected at 2.1%, while dermacosmetics are expected to grow at a rate of 15.7%, nearly seven times faster.
The size of the dermacosmetic market has more than doubled from 632.1 billion won in 2020 to 1.3079 trillion won last year, increasing its share of the overall skincare market from 9% to 17%.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.